Szpital Powiatowy W Chrzanowie
- Address
- Ul. Topolowa 16, 32-500 Chrzanow, Poland
Szpital Powiatowy W Chrzanowie - Respiratory Disease Research Center
Szpital Powiatowy W Chrzanowie is a clinical research facility specializing in respiratory medicine, with particular emphasis on chronic and acute pulmonary conditions. The center demonstrates significant expertise in evaluating novel biologic therapies for chronic obstructive pulmonary disease (COPD) and severe viral lung infections, contributing to the advancement of treatment options for patients with complex respiratory disorders.
- Chronic Obstructive Pulmonary Disease (COPD) exacerbation prevention studies
- Severe viral lung infections requiring supplemental oxygen therapy
- Novel monoclonal antibody therapies for respiratory conditions
The research center focuses on investigating advanced therapeutic interventions, including tozorakimab and tezepelumab, targeting inflammatory pathways in respiratory disease. Their clinical trial portfolio encompasses both emergency care scenarios, such as critically ill patients requiring respiratory support, and chronic disease management for former smokers with moderate to very severe COPD. This dual focus positions the center at the forefront of both acute and long-term respiratory care research.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1AstraZeneca AB2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Szpital Powiatowy W Chrzanowie
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease: A Phase III Randomized Controlled Trial | AstraZeneca AB | Phase III | Recruiting | Jun 2025 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Tozorakimab | 2 | Unknown | 2023-01-09 | 2024-02-12 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.